It is a pharma private limited company based in Lucknow, Uttar Pradesh, India, established in 2022.
2022 | Lucknow, Uttar Pradesh, India | ActiveUltravalue Pharmaceuticals Private Limited, a active private limited company, was established on 10 June 2022 in Lucknow, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51900UP2022PTC165514. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.
Formerly known as Puralma Pharmaceuticals Private Limited. Employing 75 professional, Its leadership includes Purshottam Kant Bajpai (Director), Lalan Singh (Director), Amit Kumar Anit (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Basement, 26/11, Radiant Apartment Wazir Hasan Road, Lucknow, Uttar Pradesh, 226001.
U51900UP2022PTC165514
165514
10 June 2022
₹5.00 M
₹5.00 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Ultravalue Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Purshottam Kant Bajpai | Director | 10 Jun 2022 | Current |
| Lalan Singh | Director | 10 Jun 2022 | Current |
| Amit Kumar Anit | Director | 10 Jun 2022 | Current |
| Mahesh Prasad Singh | Director | 10 Jun 2022 | Current |
| Rakesh Kumar | Director | 10 Jun 2022 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ultravalue Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Ultravalue Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Ultravalue Pharmaceuticals has a workforce of 75 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ultravalue Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ultravalue Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ultravalue Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Ultravalue Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
The activity Purshottam Kant Bajpai was appointed as a Director was appointed as a Director on 10 Jun 2022 & has been associated with this company since 3 years 6 months . was completed.
Lalan Singh was appointed as a Director was appointed as a Director on 10 Jun 2022 & has been associated with this company since 3 years 6 months . was recorded as a recent event.
Amit Kumar Anit was appointed as a Director was appointed as a Director on 10 Jun 2022 & has been associated with this company since 3 years 6 months . was recorded as a recent event.
Progress on Mahesh Prasad Singh was appointed as a Director was appointed as a Director on 10 Jun 2022 & has been associated with this company since 3 years 6 months . was documented.
The CIN of Ultravalue Pharmaceuticals Private Limited is U51900UP2022PTC165514.
Ultravalue Pharmaceuticals Private Limited is headquartered at Basement, 26/11, Radiant Apartment Wazir Hasan Road, Lucknow, Uttar Pradesh, 226001.
Ultravalue Pharmaceuticals Private Limited was incorporated on 10 June 2022.
The current directors of Ultravalue Pharmaceuticals Private Limited are
The primary industry of Ultravalue Pharmaceuticals Private Limited is Pharma.
Ultravalue Pharmaceuticals Private Limited is unlisted.
The authorized capital of Ultravalue Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX